TR201010212A2 - Sefdinir içeren katı oral dozaj formu. - Google Patents

Sefdinir içeren katı oral dozaj formu.

Info

Publication number
TR201010212A2
TR201010212A2 TR2010/10212A TR201010212A TR201010212A2 TR 201010212 A2 TR201010212 A2 TR 201010212A2 TR 2010/10212 A TR2010/10212 A TR 2010/10212A TR 201010212 A TR201010212 A TR 201010212A TR 201010212 A2 TR201010212 A2 TR 201010212A2
Authority
TR
Turkey
Prior art keywords
dosage form
oral dosage
solid oral
form containing
containing cefdinir
Prior art date
Application number
TR2010/10212A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2010/10212A priority Critical patent/TR201010212A2/tr
Priority to PCT/TR2011/000273 priority patent/WO2012078121A2/en
Publication of TR201010212A2 publication Critical patent/TR201010212A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Mevcut buluş, aktif ajan olarak sefdinir içeren farmasötik bileşimlere ve bu bileşimlerin hazırlanmasında kullanılacak bir üretim yöntemine ilişkindir.
TR2010/10212A 2010-12-08 2010-12-08 Sefdinir içeren katı oral dozaj formu. TR201010212A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2010/10212A TR201010212A2 (tr) 2010-12-08 2010-12-08 Sefdinir içeren katı oral dozaj formu.
PCT/TR2011/000273 WO2012078121A2 (en) 2010-12-08 2011-12-02 Solid oral dosage form comprising cefdinir

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/10212A TR201010212A2 (tr) 2010-12-08 2010-12-08 Sefdinir içeren katı oral dozaj formu.

Publications (1)

Publication Number Publication Date
TR201010212A2 true TR201010212A2 (tr) 2012-06-21

Family

ID=45491749

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/10212A TR201010212A2 (tr) 2010-12-08 2010-12-08 Sefdinir içeren katı oral dozaj formu.

Country Status (2)

Country Link
TR (1) TR201010212A2 (tr)
WO (1) WO2012078121A2 (tr)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA836918B (en) 1982-09-30 1984-05-30 Fujisawa Pharmaceutical Co 7-substituted-3-vinyl-3-cephem compounds and processes for the production of the same
DK1166651T3 (da) * 1996-02-29 2005-05-30 Fujisawa Pharmaceutical Co Hurtigt disintegrerende granulat af et syntetisk södemiddel indeholdende kiselsyre og/eller siliciumdioxid
US20050131079A1 (en) * 2003-12-10 2005-06-16 Pujara Chetan P. Cefdinir oral suspension
US20050245738A1 (en) * 2004-05-03 2005-11-03 Lupin Ltd Stable bioavailable crystalline form or cefdinir and a process for the preparation thereof
JP2007077123A (ja) * 2005-09-16 2007-03-29 Shiono Chemical Co Ltd 非晶質セフジニル、その製造方法およびこれを含有する経口投与用医薬組成物
CN101002745A (zh) * 2005-09-26 2007-07-25 刘凤鸣 头孢地尼的缓释制剂
US20070128268A1 (en) * 2005-12-07 2007-06-07 Herwig Jennewein Pharmaceutical compositions comprising an antibiotic
WO2007086078A2 (en) * 2006-01-30 2007-08-02 Panacea Biotec Ltd. Novel pharmaceutical compositions and process of preparation thereof
US20090275552A1 (en) * 2006-04-28 2009-11-05 Mahesh Vithalbhai Patel Therapy for Treating Resistant Bacterial Infections
KR100990223B1 (ko) * 2008-02-21 2010-10-29 주식회사 중외제약 세프디니르의 용출속도를 개선한 약제학적 조성물
CN101352424A (zh) * 2008-09-16 2009-01-28 天津市中央药业有限公司 头孢地尼分散片及其制备方法
TR200909785A1 (tr) * 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.
TR200909787A2 (tr) * 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
TR201001417A1 (tr) * 2010-02-25 2011-09-21 Sanovel İlaç San. Ve Ti̇c. A. Ş. Geliştirilmiş çözünme hızına sahip sefdinir formülasyonu
CN101862307A (zh) * 2010-03-19 2010-10-20 杭州奥默医药技术有限公司 硫酸氢头孢地尼钠胶囊及其制备方法
WO2011139252A2 (en) * 2010-05-04 2011-11-10 Mahmut Bilgic Efervescent formulations comprising cefdinir

Also Published As

Publication number Publication date
WO2012078121A3 (en) 2012-08-23
WO2012078121A2 (en) 2012-06-14

Similar Documents

Publication Publication Date Title
EA201270741A1 (ru) Пероральные композиции и липофильные соли метилналтрексона
SG194469A1 (en) Tetrahydroquinoline derivatives useful as bromodomain inhibitors
MX348823B (es) Formulaciones estables de linaclotida.
MX2019012939A (es) Formulaciones que contienen linaclotida para administracion oral.
EA201590491A1 (ru) Иммуногенная композиция
EA201291211A1 (ru) Фармацевтические композиции, содержащие гидроморфон и налоксон
MX340983B (es) Composiciones farmaceuticas y nutraceuticas de acido abscisico.
EA201201109A1 (ru) Прасугрель в тонкоизмельченной кристаллической форме и фармацевтическая композиция, содержащая его
TR201906685T4 (tr) Kristalin macitentan içeren farmasötik bileşim.
TR201009167A2 (tr) Sefalosporin içeren farmasötik granüller.
MY163476A (en) Oral care compositions
EA201390950A1 (ru) Гомогенные фармацевтические пероральные лекарственные формы, содержащие лерканидипин и эналаприл или их фармацетически приемлемые соли совместно с органической кислотой
MX359887B (es) Composicion masticable para administracion oral y proceso para preparar la misma.
TR200909785A1 (tr) Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.
PH12015501251A1 (en) Compositions and methods for treating dental caries
EA201500313A1 (ru) Стабилизированная аморфная форма агомелатина, способ ее изготовления и фармацевтические композиции, ее содержащие
TR201005327A2 (tr) Sinerjik farmasötik formülasyonlar.
TR201010859A2 (tr) Sefdinir içeren tablet formları.
TR200906506A2 (tr) Telmisartan içeren katı dozaj formları.
TR201009166A2 (tr) Sefdinir içeren farmasötik bileşim için üretim yöntemi
TR201010212A2 (tr) Sefdinir içeren katı oral dozaj formu.
TR201100152A2 (tr) Amlodipin içeren efervesan bileşimler.
TR201109160A2 (tr) Eplerenon içeren yeni farmasötik kompozisyonlar.
TR201009165A2 (tr) Sefdinir içeren tabletler
TR201009399A2 (tr) Hızlı çözünen efervesan rosuvastatin formülasyonları.